This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Beijing University of Technology. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Chris Porter: Innovator in Lymphatic Drug Delivery
Introduction
Chris Porter is an accomplished inventor based in South Melbourne, Australia. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative drug delivery systems. With a total of two patents to his name, Porter is recognized for his work in enhancing the efficacy of pharmaceutical agents.
Latest Patents
Porter's latest patents focus on lymph directing prodrugs. These inventions relate to compounds designed to promote the transport of pharmaceutical agents to the lymphatic system. By enhancing the release of the parent drug, these prodrugs aim to improve therapeutic outcomes for patients.
Career Highlights
Chris Porter is affiliated with the Beijing University of Technology, where he continues to advance research in drug delivery systems. His work has garnered attention for its potential to revolutionize how medications are administered and absorbed in the body.
Collaborations
Porter collaborates with notable colleagues, including Jamie Simpson and Natalie Trevaskis. Together, they contribute to the ongoing research and development of innovative pharmaceutical solutions.
Conclusion
Chris Porter stands out as a key figure in the field of pharmaceutical innovation, particularly with his work on lymph directing prodrugs. His contributions are paving the way for more effective drug delivery methods, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile